
The Israeli military on Sunday reported attacks on Tehran and other targets aimed at Iranian infrastructure and power structures.
Iran's Fars news agency, which is linked to the Islamic Revolutionary Guard Corps (IRGC), reported missiles striking a residential area to the south of Tehran. Ten people had died in the attack, including six Afghan migrants, Fars said.
The US-based Human Rights Activists in Iran (HRANA) reported on Saturday that the attacks on Iran over recent days had been the heaviest since the current war began on February 28. HRANA said that 74% of the attacks had targeted the Tehran region.
The organization put the casualty toll thus far at 3,400 killed, including at least 1,500 civilians.
Iranian forces continued attacks on Israel. Air raid sirens were heard in cities in the south of the country. Israel's Magen David Adom emergency medical service said there were no reports of injury. Iranian media confirmed the attacks.
Israeli media reported the attacks had targeted Dimona in the Negev desert, where Israel's nuclear reactor is located.
An attack a week ago caused dozens of injuries and destruction to a residential area.
LATEST POSTS
- 1
The Significance of Health Projects in Senior Protection. - 2
'Dancing With the Stars' Season 34 finale: Who might win the mirror ball trophy? Where do the remaining contestants rank? - 3
Historic underwater structure discovered by divers off French coast - 4
Figure out How to Utilize Your Web based Advertising Degree to Break into the Tech Business - 5
Remarkable Spots for Hot Air Swelling All over The Planet
5 Fundamental Ways to employ a Criminal Legal counselor
My Enterprising Excursion: Building a Startup
Five held on suspicion of planning attack on German Christmas market
The Best Internet based Courses for Expertise Improvement
Fears of global aluminum shortages intensify
Tributes pour in for James Ransone, 'The Wire' actor who died at 46
Scientists find new clues to why female fertility declines with age
The most effective method to Pick The Right Speakers
BioMarin to acquire Amicus Therapeutics for $4.8 billion in rare disease bet













